Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis

Birgit Ey1, Annette Eyking, Magdalena Klepak

  • 1Division of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.

Insights

Genetic defects in multidrug resistance (MDR1) and Toll-like receptor 2 (TLR2) genes promote severe ulcerative colitis (UC). Commensal bacteria trigger pyroptosis via MyD88 and IL-1R signaling, driving inflammation in UC.

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Variants of the multidrug resistance gene (MDR1/ABCB1) are linked to increased ulcerative colitis (UC) susceptibility.
  • Toll-like receptor (TLR)/interleukin-1 receptor (IL-1R) signaling pathways, including MyD88, are implicated in chronic inflammation.

Purpose of the Study:

  • To investigate the role of TLR/IL-1R signaling and MyD88 in the pathogenesis of colonic inflammation in MDR1A-deficient mice.
  • To explore the link between specific gene variants (TLR2, MDR1) and UC severity in patients.

Main Methods:

  • Generation of double- or triple-null mice lacking TLR2, MD-2, MyD88, and MDR1A.
  • Analysis of immune responses, including myeloid cell expansion and T-helper cell profiles.
  • Assessment of IL-1β production, reactive oxygen species, caspase-1 activation, and pyroptosis.
  • Comparison of caspase-1 expression and cell death in UC patients with and without specific gene variants.

Main Results:

  • Deletion of TLR2 in MDR1A-deficient mice led to fulminant pancolitis, characterized by myeloid cell expansion and TH1 responses.
  • Colitis exacerbation required intact commensal microbiota and the LPS coreceptor MD-2.
  • IL-1β production and inflammation were dependent on MyD88 and IL-1R signaling.
  • TLR2/MDR1A-deficient myeloid cells exhibited hyperresponsiveness to LPS, leading to pyroptosis and excessive IL-1β release.
  • UC patients with TLR2-R753Q and MDR1-C3435T polymorphisms showed increased caspase-1 expression and cell death.

Conclusions:

  • Combined defects in MDR1A and TLR2 facilitate spontaneous colitis progression via MD-2/IL-1R/MyD88 signaling.
  • Commensally induced pyroptosis is identified as a key innate immune mechanism in severe UC pathogenesis.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...